儿童精神药物处方的医疗补助质量改进合作组织。
A Medicaid Quality Improvement Collaborative on Psychotropic Medication Prescribing for Children.
机构信息
When this work was done, Dr. Thackeray was with the Ohio Department of Medicaid, Columbus, where Dr. Applegate is affiliated. Dr. Thackeray is now with the Center for Community Health and Advocacy, Dayton Children's Hospital, Dayton, Ohio. Dr. Crane is with the Government Resources Center, Ohio Colleges of Medicine, Columbus. Dr. Fontanella is with the Center for Psychiatry and Behavioral Health, Ohio State University, Columbus. Dr. Sorter is with the Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati. Dr. Baum is with the Division of Developmental Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column.
出版信息
Psychiatr Serv. 2018 May 1;69(5):501-504. doi: 10.1176/appi.ps.201700547. Epub 2018 Mar 1.
A Medicaid statewide quality improvement (QI) collaborative was developed to improve antipsychotic prescribing practices for children. With use of a multistrategy approach that incorporated data-driven feedback and evidence-based recommendations, improvements were seen in three measures: antipsychotics prescribed to children under age six, prescription of two or more concomitant antipsychotics for longer than two months, and prescription of four or more psychotropic medications. Challenges and complexities are reviewed, including use of ongoing QI to address factors influencing antipsychotic prescribing behaviors, engagement of providers in QI efforts, and financial sustainability of such efforts.
一个面向全州的医疗补助质量改进（QI）合作组织成立了，旨在改善儿童抗精神病药物的使用情况。通过采用多策略方法，结合数据驱动的反馈和基于证据的建议，在三个方面取得了改进：六岁以下儿童开的抗精神病药物、两种或两种以上同时开的抗精神病药物超过两个月，以及四种或四种以上精神药物的处方。审查了挑战和复杂性，包括使用持续的 QI 来解决影响抗精神病药物处方行为的因素、提供者参与 QI 工作，以及这些工作的财务可持续性。
Zotero 插件